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Stable isotope labeling by amino acids in cell culture
(SILAC) has become a versatile tool for quantitative,
mass spectrometry (MS)-based proteomics. Here,
we completely label mice with a diet containing either
the natural or the 13C6-substituted version of lysine.
Mice were labeled over four generations with the
heavy diet, and development, growth, and behavior
were not affected. MS analysis of incorporation
levels allowed for the determination of incorporation
rates of proteins from blood cells and organs. The F2
generation was completely labeled in all organs
tested. SILAC analysis from various organs lacking
expression of b1 integrin, b-Parvin, or the integrin
tail-binding protein Kindlin-3 confirmed their ab-
sence and disclosed a structural defect of the red
blood cell membrane skeleton in Kindlin-3-deficient
erythrocytes. The SILAC-mouse approach is a versa-
tile tool by which to quantitatively compare pro-
teomes from knockout mice and thereby determine
protein functions under complex in vivo conditions.
INTRODUCTION
The administration of radioactive or stable isotope tracers to
animals is a well established technique by which to investigate
the rate of protein synthesis and protein degradation. (Wolfe
and Chinkes, 2005). This technology has been used for many
decades (Schoenheimer and Rittenberg, 1935). The infusion of
stable isotopes (13C or 15N) as tracers combined with measure-
ments of 13CO2 or
15N in urinary urea or ammonia is a broadly
used technique by which to explore the amino acid flux in meta-
bolic pathways (Bier, 1997; Dietz et al., 1982). Extensive incorpo-
ration of 13C or 15N stable isotopes does not result in discernable
health effects of the treated animals (Doherty and Beynon, 2006;
Gregg et al., 1973).Mass spectrometry (MS) is not inherently quantitative, and rel-
ative protein expression changes are instead most accurately
measured by comparison of the natural form of a peptide with
its stable isotope analog (Ong and Mann, 2005). In recent years,
15N labeling has been applied to microorganisms such as yeast
(Oda et al., 1999; Pratt et al., 2002), Caenorhabditis elegans, and
Drosophila (Krijgsveld et al., 2003). Even a rat has been partially
(Wu et al., 2004) or completely 15N labeled (McClatchy et al.,
2007). In addition, nonsaturated labeling of a chicken, by using
the essential amino acid valine, allows for theMS-based analysis
of protein turnover rates in vivo (Doherty et al., 2005).
Our laboratory has previously described stable isotope label-
ing by amino acids in cell culture (SILAC) (Mann, 2006; Ong
et al., 2002), which has unique advantages for quantitative and
functional proteomics because of its inherent accuracy of quan-
titation and the ease of interpretation of MS results (Blagoev
et al., 2004; Kratchmarova et al., 2005). In a SILAC experiment,
two cell populations are generated: one in a medium that con-
tains the natural amino acid (i.e., 12C6-lysine), and the other in
a medium that contains the heavy isotope-substituted version
(i.e., 13C6-lysine). This allows for direct comparison of protein ex-
pression levels by mixing the nonlabeled ‘‘light’’ and the labeled
‘‘heavy’’ cell populations (Cox and Mann, 2007). Each peptide
appears as a pair in MS analysis with a difference in mass of
6 Da, and the relative peak intensities reflect the abundance
ratios. To date, SILAC labeling has been limited to cell culture
or microorganisms. To extend this powerful technique to higher
organisms, Oda and coworkers have SILAC labeled the Neuro
2A cell line to serve as an internal standard for quantitation of
a subset of peptides of the mouse brain proteome (Ishihama
et al., 2005).
In the present paper, we report the development of a mouse
SILAC diet that leads to complete labeling of the F2 generation.
We used in vivo SILAC quantitation to analyze newly synthesized
proteins from plasma and tissue samples in vivo. Furthermore,
we validated our in vivo quantitation system by comparing the
proteomes from platelets, heart, and erythrocytes from b1 integ-
rin-, b-Parvin-, and Kindlin-3-deficient mice, respectively.
Integrins are heterodimeric transmembrane proteins, consist
of a and b subunits, are ubiquitously expressed, and performCell 134, 353–364, July 25, 2008 ª2008 Elsevier Inc. 353
cell-cell and cell-matrix adhesion functions. Association of the
corresponding a and b subunits is required for their stability
and transport to the plasma membrane, as single subunits are
not stable and are rapidly degraded. Integrin-mediated cell
adhesion triggers intracellular signaling pathways (outside-in
signaling) that control migration, proliferation, survival, and dif-
ferentiation of cells. Prior to ligand binding, integrins require an
energy-dependent activation step, which is triggered within the
cell (inside-out signaling) and is characterized by a profound
conformational change in both integrin subunits. Although the
mechanism(s) underlying integrin activation are far from under-
stood, it is believed that the binding of the FERM-domain-con-
taining adaptor proteins talin and Kindlin to the integrin b cyto-
plasmic domains represents the last step in the activation
pathway (Calderwood, 2004; Moser et al., 2008).
Upon activation and ligand binding, integrins recruit and as-
semble a multiprotein complex at the site of cell adhesion that
fulfils two major tasks: it connects the extracellular matrix with
the actin cytoskeleton, and it alters the fluxes of many intracellu-
lar signaling pathways. A preformed complex consisting of the
three proteins, ILK, PINCH, and Parvin, represents an important
component of the integrin adhesion complex (Legate et al.,
2006). Parvins comprise a family of three proteins, a-, b- and
g-Parvin, that directly bind to ILK, F-actin, and other actin-asso-
ciated proteins, thereby linking the adhesion complex to the
actin cytoskeleton and controlling actin dynamics.
Kindlins have recently been identified within the integrin-medi-
ated cell adhesion complex and represent an additional family of
ILK-binding proteins (Montanez et al., 2007). They consist of
three members (Kindlin-1–3) and are named after the gene mu-
tated in Kindler syndrome, an autosomal recessive skin blister
disease in humans. Kindlin-3 expression is restricted to hemato-
poietic cells, and the highest levels are inmegakaryocytes (Ussar
et al., 2006). Inactivation of the Kindlin-3 gene in mice results in
severe anemia, which is thought to be due to a bleeding defect
caused by impaired activation of platelet integrins, defects in
platelet aggregation, and thrombus formation (Moser et al.,
2008).
To screen for potential defects in other cellular compartments
of the hematopoietic system in Kindlin-3-deficient mice, we
compared their proteome with those from control mice. During
the course of these studies, we discovered a deficit of structural
proteins in the plasma membrane of Kindlin-3-deficient erythro-
cytes, which contributes to the severe anemia seen in Kindlin-3-
deficient mice.
RESULTS
A Heavy SILAC Diet Has No Influence on Weight Gain
and Fertility
We prepared a SILAC diet by mixing 13C6-lysine or
12C6-lysine
into a customized lysine-free mouse diet to a final concentration
of 1% (Figure 1A) according to standard mouse nutritional
requirements (Benevenga et al., 1995). The amino acid content
was subsequently checked by hydrolysis and cation exchange
chromatography (Figure S1 available online). We first tested
whether the diet permits normal weight gain by feeding
mice with a regular diet or the SILAC diet (with 12C6-lysine or354 Cell 134, 353–364, July 25, 2008 ª2008 Elsevier Inc.13C6-lysine). During an observation period of 4 weeks, all animals
showed the same food consumption and a similar increase in
body weight of about 17% (Figures S2A and S2B), normal fertil-
ity, andmotor activity irrespective of the diet consumed. Further-
more, we SILAC labeled mice over four generations (see below),
indicating that the labeling is compatible with normal develop-
ment and physiology. Thus, we conclude that SILAC labeling
with a 13C6-substituted essential amino acid diet does not lead
to obvious discernable health effects in mice (Figure 1B).
SILAC Incorporation Rates Differ in Blood, Liver,
and Gut Epithelium
To track 13C6-lysine incorporation into the proteome over time,
we sampled blood each week for 4 weeks. Serum proteins
were separated on 1D gels in triplicate, in-gel digested, and
analyzed by high-resolution MS. The average relative standard
deviation of all quantified proteins was20% (Figure 1C), an ac-
curacy similar to what was seen in previous SILAC quantitation
experiments (Blagoev et al., 2004; Ong et al., 2003).
As an example of different incorporation levels, SILAC peptide
pairs of three serum proteins and one red blood cell protein are
shown in Figure 1C. For serum albumin, we observed a SILAC
ratio of 1:3.2, indicating that at least 74% of the protein had
been newly synthesized during the firstweek of feeding. Because
proteins can be synthesized from dietary amino acids as well as
from amino acids derived by protein catabolism, this value is
a lower limit for the true turnover (Beynon and Pratt, 2005). After
4 weeks, the three serum proteins were labeled to 90%. In
contrast, hemoglobin was only labeled to 57% after 4 weeks
(Figure 1C), due to the 60-day half-life of mouse erythrocytes
(Berlin et al., 1959). Additional profiles of blood proteins are listed
in Table S1.
Next, we measured the labeling efficiencies of a number of
organs after 4 weeks of feeding with the SILAC diet. Proteins
from heart showed an average protein ratio of 1:4.4 (Figure 2A;
Table S2), much lower than the serum proteins. Furthermore,
the distribution of SILAC ratios was relatively broad, reflecting
the different incorporation rates of individual cell types and the
‘‘contamination’’ of serum proteins in nonperfused samples.
For example, serum albumin has a similarly high incorporation
rate in blood (ratio 9) and heart (ratio 10) (Figures 1C and 2A).
In contrast to heart tissue, in which most cells are quiescent,
the intestinal epithelium regenerates within a few days (Radtke
and Clevers, 2005). Disaggregating the epithelium from the
digestive tube resulted in a more homogeneous cell pool con-
sisting of only a few cell types. As a consequence, we observed
a high SILAC ratio of 1:9.1 ± 2.1 reflecting a labeling efficiency of
more than 90% (Figure 2B), which is fully consistent with the high
proliferation rate of this tissue. For example, villin-1, a marker for
epithelial cells from the digestive system, showed a SILAC ratio
of 1:10.
Liver has a number of different physiological roles, including
carrying out metabolic functions and producing major blood
proteins. Accordingly, we observed a wide distribution of SILAC-
incorporation ratios among liver proteins. Hepatocytes are the
predominant liver cell type, and they are very rich in mitochon-
dria. To demonstrate that in vivo SILAC ratios can be measured
with subcellular resolution, we isolated mitochondria from liver
Figure 1. SILAC Labeling and Incorporation Rates of Blood Proteins
(A) Mice are SILAC labeled by being fed a pelleted, lysine-free diet supplemented with normal or heavy lysine.
(B) Mice on a SILAC diet cannot be visually distinguished from mice with a normal, commercial diet.
(C) Mass spectra showing SILAC pairs of a representative peptide for four blood proteins. The right-hand side shows lysine-6 incorporation over the course of
4 weeks as an average measurement of triplicates.cells (Forner et al., 2006) and compared their labeling ratios to
whole-cell lysates from the same sample (Figure 2C, black
bars). Interestingly, proteins frommitochondria showed an aver-
age SILAC ratio of 1:8.6 ± 2.4. This shows that the incorporation
rates of an organelle are more narrowly distributed and distin-
guishable from that of a whole tissue.
We next investigated several cell types of the hematopoietic
system. Platelets are cell fragments that are constantly released
bymegakaryocytes into the blood stream. They have a half-life of
7–9 days. We isolated platelets from a SILAC mouse after 4
weeks of labeling and measured incorporation levels of 86%
from 241 quantified proteins (Figure 2D). In contrast, serum albu-
min, which was also measured within the platelet sample due to
serum contamination, has a much higher incorporation levelcompared to platelet proteins. Analysis of the red blood cell pro-
teome revealed a significantly lower 13C6-lysine incorporation of
75% (Figure 2E). Thus, consideration of SILAC-incorporation
rates could aid in the determination of the origin of the same
proteins from different cellular pools via their different dynamic
incorporation rates.
To combine SILAC-mouse analysis with cell sorting to obtain
an accurately defined cell population, we separated CD45R-
positive B lymphocytes from spleen by fluorescence-activated
cell sorting (FACS) (Figures 2F and S3). An in-solution protein
digest was performed from lysates of 13 106 spleen cells (Table
S2F). The distribution of measured ratios was 1:5.4 ± 1.3, dem-
onstrating that FACS-sorted populations of interest can readily
be investigated in the SILAC mouse.Cell 134, 353–364, July 25, 2008 ª2008 Elsevier Inc. 355
Figure 2. SILAC Label Incorporation into Different Cell Types and Tissues after 4 Weeks
(A–F) The panels show the relative number of proteins with the specified ratios for each proteome investigated. (A) Heart tissue. (B) Gut epithelium. (C) Incorpo-
ration into whole liver (gray bars) is compared with incorporation into liver mitochondria (black bars). (D) Platelets. (E) Erythrocytes. (F) CD45R-positive B lympho-
cytes from spleen.Taken together, our results indicate that feeding mice with
a SILAC diet is a suitable approach to label proteins in vivo
and to follow their metabolic incorporation in any organ.
Complete SILAC-Based Labeling of F2 Mice
Although the label efficiency was relatively high in many tissues,
we found that extending the labeling time did not lead to com-
plete labeling. This is likely due to the recycling of internal amino
acid sources (Doherty et al., 2005). Since labeling rates above
95% are required to perform comparative and quantitative pro-
teomics by MS, we started feeding our mice over several gener-
ations with the heavy diet. Importantly, the consumption of the
heavy diet did not affect litter size (Figure S2). The F1–F4 off-356 Cell 134, 353–364, July 25, 2008 ª2008 Elsevier Inc.spring developed normally, gained weight within the normal
weight-gain chart (Figure S2), and showed normalmating behav-
ior. Furthermore, newborn animals of the F1 generation were
almost completely labeled, reaching 93% in blood, brain, and
liver (Figures 3 and S4). To obtain fully labeled animals to serve
as internal standards and to investigate if SILAC labeling could
be performed for many generations, we bred F2, F3, and F4
mice. These mice contained virtually no unlabeled peptides
(Figures 3B, 3C, and 5A; Table S3).
Proteome of b1 Integrin-Deficient Platelets
For validation of our in vivo quantitative proteomics approach,we
analyzedandcomparedprotein lysates fromb1 integrin-deficient
and control platelets (Nieswandt et al., 2001). We generated
b1 integrin-deficient platelets by intercrossing b1 floxed mice
(b1fl/fl) with a transgenic mouse expressing an Mx1 promoter-
driven, interferon-inducible Cre (Mx1-Cre) (Brakebusch et al.,
2000; Kuhn et al., 1995). We treated b1fl/fl; Mx1-Cre mice with
synthetic double-stranded RNA (polyinosinic-polycytidylic acid,
pI-pC), which triggers endogenous interferon production and
subsequent Mx1-Cre activity. This leads to deletion of the b1 in-
tegrin gene in all hematopoietic cells, includingmegakaryocytes.
To monitor the knockout efficiency of b1 integrin, we compared
platelets from labeledwild-type animalswith platelet populations
from three groups of mice: (1) nonlabeled wild-type platelets; (2)
platelets from nonlabeled, non-pI-pC-induced b1fl/fl; Mx1-Cre
mice; and (3) platelets from nonlabeled, pI-pC-induced b1fl/fl;
Mx1-Cre mice (Figure 4). All mice were backcrossed on
a C57BL/6 background to reduce genetic variability.
Figure 3. Complete Labeling of the F2 Generation
(A) Label efficiency of the liver of a 2-day-old mouse of the F1 generation.
(B and C) Histograms of liver proteins with the specified percent incorporation
at (B) P2 and at (C) P50 of the F2 generation. The averages of the SILAC ratios
and the corresponding percent of the SILAC labeling are displayed in the histo-
gram. The analysis encompasses 100 proteins.We quantified 645 proteins in these platelets, and, as
expected, protein ratios of labeled and nonlabeled wild-type
platelets were tightly distributed, with an overall ratio of 1:1.
The quantitative MS analysis revealed complete loss of b1 integ-
rin in platelets from pI-pC-induced b1fl/fl; Mx1-Cre mice
(Figure 4F). The proteins with the next highest ratios were the di-
merization partners of the b1 integrin subunit, strikingly confirm-
ing the sensitivity and reliability of our SILAC-mouse labeling
system (Figure 4I). In a boxplot analysis, b1, a2, and a6 integrins
were all more than ten interquartile ranges away from themedian
(Figure S5A; Table S4).The complete loss of both a subunits can
be explained by the formation of a stable integrin heterodimer
during the synthesis and transport of the complexed integrin
subunits to the plasma membrane. Without the correct b integrin
subunit, the a subunit is rapidly degraded (Hynes, 2002). In con-
trast, the loss of b1 integrin has no impact on the expression of
other integrins, such as the major platelet integrin aIIbb3.
In addition, several other proteins in b1 integrin-deficient
platelets were outliers in the boxplot (Figure S5A; Table S4).
However, a second independent experiment did not verify these
proteins as being significantly downregulated. (Figure S5C). In
contrast, the b1 integrin dimerization partners a2 and a6 integ-
rins were again strongly reduced (Figure S5).
Interestingly, the analysis of platelets from noninduced b1fl/fl;
Mx1-Cre mice also revealed a slight downregulation of the b1,
a2, and a6 integrin levels compared to labeled wild-type plate-
lets (Figure 4J). This effect is due to the natural, endogenous
a/b interferon production in the bone marrow causing a low
Mx1 promoter activity (Kuhn et al., 1995). The detection of this
‘‘leak’’ impressively underscores the sensitivity of our quantita-
tive proteomics approach.
b-Parvin Deficiency in Heart Is Compensated
by a-Parvin Induction
We next wanted to confirm the applicability of our in vivo SILAC
approach to analyze the proteomes fromknockoutmice in a solid
organ. To this end, we compared the proteomes from hearts of
b-Parvin-deficient mice with those of control littermates. As
a heavy standard, we used heart lysates from 2-week-old mice
of the F4 generation, which showed an overall 97.7% incorpora-
tion of 13C-lysine (Figure 5A). To test our quantitation system, we
mixed ‘‘heavy’’ and ‘‘light’’ protein lysates from wild-type hearts
in ratios of 1:1, 1:2, and 1:4. As shown in (Figure 5B), mixing of
protein lysates from different heart samples gave rise to SILAC
ratios that accurately reflected the lysate mixture.
b-Parvin represents the dominant Parvin isoform of the heart,
since a-Parvin is only weakly present and g-Parvin is absent from
heart tissue. b-Parvin-deficient mice were generated by homol-
ogous recombination of a targeting vector in embryonic stem
(ES) cells, which lacks exons 2 and 3 of the b-Parvin gene (I.T.
and R.F., unpublished data). b-Parvin-deficient mice were viable
and fertile and did not show any overt phenotype, indicating that
b-Parvin is not essential for mouse development and organ for-
mation. Mass spectrometric measurements of whole protein ly-
sates from b-Parvin-deficient and control hearts of 2-week-old
animals showed a complete absence of b-Parvin in knockout an-
imals (Figures 5C and 5D). Out of 1205 proteins, only 4 proteins
showed a two-fold decrease in their abundance compared toCell 134, 353–364, July 25, 2008 ª2008 Elsevier Inc. 357
wild-type hearts (Table S5). Interestingly, lack of b-Parvin had no
dramatic consequence on the level of ILK and PINCH-1, which
are the two other components of the ILK/Pinch/Parvin complex.
The two-fold increase of a-Parvin in b-Parvin-deficient hearts
suggests that the absence of an obvious phenotype is due to
compensatory upregulation of a-Parvin (Figure 5C).
Kindlin-3 Deficiency Disrupts the Red Blood Cell
Membrane Skeleton
Kindlin-3-deficient mice die at birth and suffer from severe
bleeding, anemia, and pale skin color (Figures 7A and 7B; Moser
et al., 2008). To further validate the power of in vivo SILAC and to
obtain novel insights into Kindlin-3 function, we performed quan-
titative proteomics of platelets and erythrocytes fromKindlin-3/
mice. Platelet analysis identified Kindlin-3 as the protein with the
highest fold change of more than 1200 platelet proteins
(Figure S6A; Table S6). Interestingly, the levels of integrin aIIb
and b3 subunits were normal, suggesting that the reduced sur-
face levels found by FACS (Moser et al., 2008) were due to an im-
Figure 4. Analysis of b1 Integrin Knockout
Platelets
(A–J) (A, D, and G) Platelets from SILAC-labeled
wild-type mice were mixed with platelets from
a nonlabeled wild-type control mouse. Compari-
son of the wild-type SILAC mouse with (B, E, and
H) noninduced b1fl/fl; Mx1-Cre mice and with (C,
F, and I) pI-pC-induced b1fl/fl; Mx1-Cre mice. The
slight decrease of b1 integrin shown in (E) is due
to Cre activity induced by low endogenous inter-
feron expression. The arrows in (F) and (I) label
the reduced peak intensity of b1 and a2 integrin,
respectively. (J) Summary of quantified SILAC ra-
tios for b3, b1, a2, and a6 integrin subunits. White
bars represent the ratio between the labeled wild-
type WT(h) animal and the nonlabeled wild-type
animal, gray bars represent the SILAC ratio of
WT(h) and noninduced b1fl/fl, and black bars repre-
sent the SILAC ratio between WT(h) and induced
b1fl/fl; Mx1-Cre. The error bars show the variability
of the measured ratios.
paired integrin trafficking in the absence
of Kindlin-3 (Figure S6B).
We have previously reported that Kind-
lin-3 (also known as ‘‘unc-related protein
2’’) is present in red blood cells (Pasini
et al., 2006). This was confirmed by dif-
ferent SILAC-incorporation levels in
platelets (incorporation rate of 1:6.0) com-
pared to erythrocytes (incorporation rate
of 1:2.1), measured after the initial 4-week
labeling period (Figures 2, S7A, and
S7B). Furthermore, Kindlin-3 gene activity
in Ter119-positive Kindlin-3-heterozy-
gous erythroblasts was further corrobo-
rated by measuring Kindlin-3 promoter-
driven b-galactosidase reporter gene
activity with FACS (Figure S7C).
To investigate whether loss of Kindlin-3 affects erythroid cells,
we determined and quantitatively compared the proteomes from
wild-type, Kindlin-3+/, and Kindlin-3/ erythrocytes (Figure 6;
Table S7). MS confirmed a 50% reduction of Kindlin-3 in hetero-
zygous and a complete absence of Kindlin-3 in Kindlin-3/
erythrocytes (Figure 6A).Out of 881 proteins identified in all 3 pro-
teomes, more than 50 were two-fold increased in Kindlin-3/
erythrocytes, andonlya few revealedamore than two-fold reduc-
tion. Interestingly, a large proportion of the upregulated proteins
was annotated to be nuclear (Table S7).
Blood smears from Kindlin-3/ embryos and P3 animals
showed a strong reduction of cells when compared to wild-
type controls and, in concordance with this proteomic finding,
manymore nucleated erythroblasts (Figures 7B and 7C). In addi-
tion, the size and shape of Kindlin-3/ erythrocytes were mark-
edly irregular.
Scanning electron microscopy showed abnormally shaped
erythrocytes with striking membrane invaginations and protu-
berances (Figure 7D). Red blood cell membrane abnormalities358 Cell 134, 353–364, July 25, 2008 ª2008 Elsevier Inc.
are often caused by mutations within membrane-skeleton pro-
teins, and the absence of key components can have drastic con-
sequences on the stability of the red cell membrane (Delaunay,
1995). To obtain an explanation for the structural defects, we
quantitatively compared the membrane-skeleton proteins from
total erythrocytes by using SILAC-based MS. The levels of the
most prominent skeleton proteins (e.g., a/b spectrin, ankyrin,
band 3, band 4.1, band 4.2, and actin) did not significantly differ
between wild-type and Kindlin-3/ mice.
Next, we determined whether these proteins have formed
a stable meshwork that is connected with the erythrocyte mem-
brane. To address this question, we isolated the erythrocyte
membranes (so called red blood cell ‘‘ghosts’’) from wild-type
Figure 5. Analysis of Heart Tissue from
b-Parvin Knockout Mice
(A) 13C6-Lysine incorporation of heart tissue from
mice of the F4 generation shows a label efficiency
of 97.7%.
(B) Heart tissue from labeled and nonlabeled ani-
malswasmixed1:1, 1:2, and1:4. ThemeasuredSI-
LAC ratios after in-solution digestion were 0.93 ±
0.17 for the 1:1 mix, 0.58 ± 0.10 for the 1:2 mix,
and 0.26 ± 0.05 for the 1:4 mix. Approximately
300 SILAC protein ratios were used for the quanti-
fication.
(C) Heart tissue from SILAC-labeled wild-type
mice was mixed with nonlabeled b-Parvin (+/+)
and b-Parvin (/) hearts. The arrow indicates
the complete absence of b-Parvin.
(D) SILAC ratios of selected proteins.
and Kindlin-3/ mice and compared
them to ghosts from SILAC-labeled con-
trol animals (Figure 7E). Quantitative
SILAC-based analysis revealed an almost
complete absence of ankyrin-1, band 4.1,
adducin-2, and dematin (Figure 7F, right
rows; Table S8), whereas other mem-
brane-skeleton proteins, like a/b spectrin
and band 3, were not changed.
Together, these findings show that
Kindlin-3 is required for the assembly of
a subset of proteins within the red blood
cell membrane skeleton. Furthermore,
the proteomic, morphological, and func-
tional data provide a clear explanation
for the anemia that leads to postnatal
lethality.
DISCUSSION
Thus far, quantitative gene expression
comparisons in higher organisms have
been restricted to RNA analyses by gene
chip approaches. These methods have
many advantages: for example, ready
accessibility and the fact that, in principle,
almost all genes can be analyzed on one
chip. However, because of posttranscriptional regulation as
well as regulated protein degradation, these data do not neces-
sarily predict changes in protein levels within cells or tissues.
Furthermore, there are specific cell populations, such as the
platelets and erythrocytes investigated here, that are devoid of
mRNA and are therefore out of reach for these techniques.
Here, we show that SILAC, a versatile and successful method
for quantitative proteomics in cell culture-based systems or mi-
croorganisms, can be extended to mammalian model systems.
Mice can be SILAC labeled without any obvious effect on
growth, behavior, or fertility. SILAC food preparation is straight-
forward and not particularly expensive when considering other
resources required for the generation and maintenance ofCell 134, 353–364, July 25, 2008 ª2008 Elsevier Inc. 359
knockout animals. We chose 13C6-lysine labeling, as lysine is not
converted into other amino acids. This makes endoprotease
Lys-C the preferred choice as the proteolytic enzyme. Another
interesting enzyme for SILAC mice is Lys-N, which has recently
been described as an efficient enzyme for proteomics and de
novo peptide sequencing (Taouatas et al., 2008). Organs derived
from SILAC mice can serve as standards for a large number of
subsequent experiments, in which wild-type and knockout
mice are compared. Importantly, cell types such as intestinal
epithelium that are difficult to study ex vivo can be analyzed by
the in vivo SILAC approach. Moreover, the SILAC mouse can
serve as a reference model at any biological scale, from the
whole organ through specific cell types down to intracellular
compartments or single proteins of interest. As an example,
we used SILAC mice to successfully study the mitochondrial
proteome, which can be extended to investigations in relevant
organs from metabolic or neurodegenerative disease models.
In studies in which a large number of mice are required—such
as in toxicology studies—labeled organ tissue could be stored
and used as an internal standard for each measurement. A la-
beled SILAC-mouse liver, for example, yields sufficient internal
standard for more than 1000 measurements. Although not
shown here, phosphopeptides can also be enriched from SILAC
mice and can serve as a standard for functional and time-
resolved phosphoproteomics (Olsen et al., 2006).
We analyzed the proteomes of cells from three independent
knockout mice. In all analyses, the complete absence of the tar-
geted genes was immediately revealed by the SILAC technique.
Furthermore, heterozygous Kindlin-3 animals present the ex-
pected two-fold reduction from wild-type levels, emphasizing
the quantitative nature of our proteomic technology. This may
be particularly useful in quantifying knockdown efficiencies in
Figure 6. Quantitative Proteomics of Erythrocytes
from Kindlin-3/ Mice
(A) Mass spectra of a Kindlin-3 peptide SILAC pair in Kindlin-
3+/+, Kindlin-3+/, and Kindlin-3/ erythrocytes.
(B) Histogram of SILAC ratios of wild-type (white bars) and
Kindlin-3/ (gray bars) erythrocytes. The measured ratios
were grouped into ratio bins, and the y axis shows the relative
number of detected ratios per bin.
transgenic RNAi mice. The sensitivity of the
SILAC-based quantitation system became remark-
ably obvious by an observation from the b1 integrin
inactivation in platelets. Deletion of the b1 integrin
gene in hematopoietic cells is achieved by the
induction of the Mx1-Cre transgene through the
injection of pI-pC into b1 integrin floxed animals.
Even without induction of Cre, the low expression
levels of naturally expressed a/b interferon acti-
vated the Mx1 promoter and triggered b1 integrin
deletion in a few cells. Even this slight difference
in total b1 integrin expression proved sufficient for
detection by the SILAC method.
Our proteomic data on platelets of b1 integrin
mice showed that, although integrins control a num-
ber of different signaling pathways, the lack of the
b1 integrin has no consequences on the levels of other proteins
in platelets, apart from its dimerization partners a2 and a6 integ-
rins. This may be due to the fact that, in resting platelets, integ-
rins are inactive and signaling into the cell is only induced upon
stimulation via molecules like thrombin or collagen (Ruggeri,
2002). Further studies with the SILAC-mouse system could
focus on activation of signaling cascades during platelet aggre-
gation by using phosphoproteomics.
To test the SILAC-based analysis in a solid organ system, we
compared the proteomes from heart of b-Parvin-deficient mice
with control littermates. The complexity of a tissue, formedby dif-
ferent cell types, poses no limitation for the quantitative analysis
by MS. The interpretation of results, however, is more challeng-
ing because changes in protein levels may result from non-cell-
autonomous defects caused, for example, by altered cell-cell
communication rather than cell-autonomous defects.
To study the molecular cause of the anemia observed in Kind-
lin-3 mutants, we analyzed the consequences of this deletion on
the proteome of platelets and erythrocytes. Recently, we char-
acterized Kindlin-3 as an essential factor for the activation of
platelet integrins (Moser et al., 2008). Kindlin-3 directly binds to
the cytoplasmic tails of both b1 and b3 integrin subunits. Its ex-
pression is restricted to cells of the hematopoietic system (Ussar
et al., 2006). Our SILAC-based analysis of Kindlin-3-deficient
erythrocytes revealed an increased amount of nuclear proteins,
prompting us to investigate consequences of the knockout on
this cell type. Consistent with the proteomic results, we found
an increased number of nucleated erythroblasts in blood
smears. Furthermore, Kindlin-3-deficient erythrocytes are irreg-
ular in size and shape. The structural defects of the red blood
cell membrane skeleton suggested an additional function of
Kindlin-3. With the help of the SILAC method, we quantitatively360 Cell 134, 353–364, July 25, 2008 ª2008 Elsevier Inc.
compared the membrane-skeleton proteins of control and Kind-
lin-3-deficient erythrocytes and revealed a critical role of Kindlin-
3 in the formation or stabilization of this structure. The inner sur-
face of the red blood cell membrane is laminated by a protein
network that is linked to transmembrane proteins. In humans
and mice, mutations in genes encoding ankyrin, band 3, spec-
trin, and protein 4.1 or protein 4.2 cause hereditary spherocyto-
sis or poikilocytosis, often accompanied with hemolytic anemias
(Delaunay, 1995; Peters et al., 1998; Rybicki et al., 1995; Shi
et al., 1999; Southgate et al., 1996). The dramatic reduction of
ankyrin-1, protein 4.1, and dematin in membrane preparations
from Kindlin-3-deficient erythrocytes explains the severe
Figure 7. Kindlin-3-Deficient Erythrocytes Show Disrupted Membrane Skeletons
(A) Kindlin-3 knockout mice are anemic.
(B) Decreased hematocrit in Kindlin-3/ mutants at embryonic day 15 and P3.
(C) Blood smears from E15 embryos and P3 wild-type and Kindlin-3/ mice reveal fewer erythrocytes and an increased number of nucleated erythroblasts.
(D) Scanning electron microscopy of wild-type and Kindlin-3/ erythrocytes. The scale bar represents 1 mm.
(E) ‘‘Ghost’’ lysates from wild-type, heterozygous, and Kindlin-3/mice were stained by Coomassie blue after SDS-PAGE. The arrows indicate the absence of
proteins within the membrane-skeleton fraction of Kindlin-3/ erythrocytes.
(F) SILAC-ratio comparison of total erythrocytes (left rows) and the membrane fraction (right row).Cell 134, 353–364, July 25, 2008 ª2008 Elsevier Inc. 361
malformations. Thus, loss of Kindlin-3 affects erythropoiesis by
disrupting the assembly of structural components within the
red blood cell membrane skeleton.
In summary, a direct combination of the SILAC technology for
quantitative proteomics with the large number of powerful
mouse models generated by the community is now possible.
We have demonstrated here how proteomics can be combined
with several of the powerful technologies already used in this en-
deavor. We are confident that this technology will help to eluci-
date disease processes and guide novel intervention strategies.
Data Availability
Data used for quantitation accompany this article online.
EXPERIMENTAL PROCEDURES
Materials and Reagents
13C6-Lysine (98 atom %
13C) was purchased from Silantes, Martinsried, Ger-
many. Chemicals for the ‘‘in-solution’’ and ‘‘in-gel’’ digests were purchased
from Sigma-Aldrich, and LysC was obtained from WAKO. Wild-type mice
were obtained from an in-house C57Bl/6 colony.
Knockout Mice
Transgenic mice expressing the Cre recombinase under the control of theMx1
promotor (Kuhn et al., 1995) were mated with mice carrying a floxed b1 integrin
gene (Brakebusch et al., 2000). To ensure extensive downregulation of the b1
integrin on platelets, pI-pC (250 mg per mouse) (Amersham) was injected intra-
peritoneally three times in a 2-day interval.
Kindlin-3-deficient mice were generated as described byMoser et al. (2008).
A detailed description of the b-Parvin gene inactivation will be published else-
where (I.T. and R.F., unpublished data).
Food Preparation, Weight Gain, and Food Consumption
A customized lysine-free mouse diet (Harlan-Teklad, TD.99386) was com-
bined with the heavy L-13C6-lysine and the natural isotope L-lysine (Sigma) to
a final concentration of 1%. To obtain a homogenous distribution of the amino
acid, the powder was vigorously mixed with a blender for 5 min. For the prep-
aration of food pellets, 10 g of the mixture was filled into an in-house-manu-
factured cylinder with an inner diameter of 1.5 cm and a length of 10 cm. Food
was compressed with an exactly fitting pestle for 1 min. Pellets were taken out
and dried overnight at room temperature. After drying, the pellets were cut into
smaller pieces.
The lysine content was checked as described (Moore et al., 1958). Although
the hydrolysis with subsequent chromatography does not allow for the exact
determination of the amino acid contents, the supplemented lysine amount
was comparable to that in the customized diet containing the natural lysine
isotope.
For testing weight gain and food consumption, one group (n = 3 females)
was fed with a regular mouse diet, one group (n = 3 females) was fed with
the customized lysine-free diet supplemented with natural lysine (Sigma),
and one animal was fed with the diet containing the heavy isotope for lysine.
All animals were fed ad libitum and had access to water.
Food consumption was measured daily for 10 days during breeding and
weaning periods (Figure S2). The label percentage was calculated as the
mean of the heavy-labeled peptide signal divided by the sum of the light and
heavy signals.
Sample Preparation
Blood Samples
Mice were anesthetized with isofluran, and 20 ml blood was taken from the
retro-orbitral plexus. Blood samples were incubated with heparin (20 U/ml),
and, after centrifugation, the supernatant was frozen in liquid nitrogen and
stored at 80C.362 Cell 134, 353–364, July 25, 2008 ª2008 Elsevier Inc.Tissue Harvest
After sacrificing animals by cervical dislocation, tissues were dissected,
washed in phosphate-buffered saline (PBS [pH 7.4]), and frozen in liquid nitro-
gen. For protein isolation, tissues were homogenized in a buffer containing 1%
NP-40, 0.1% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 50 mM Tris
(pH 7.5), and protease inhibitors (Complete tablets, Roche).The lysates were
centrifuged at 14,000 3 g to pellet cellular debris. A Bradford assay was per-
formed to determine protein concentrations of the supernatants.
Mitochondria Isolation
Liver tissue was quickly washed in water, then washed three times in 250 mM
sucrose, 10 mM Tris-HCl, 0.1 mM EGTA (pH 7.4) supplemented with protease
inhibitors (Roche). Crude mitochondria were isolated as described previously
(Forner et al., 2006) and were purified on a 30% Percoll density centrifugation
gradient.
Platelets were isolated by differential centrifugation steps as described by
Moebius et al. (2005).
Epithelial Cell Isolation from Gut
Small intestine was cut open and washed with PBS. The small intestine was
transferred to dissociation buffer (130 mMNaCl, 10 mM EDTA, 10 mMHEPES
[pH 7.4], 10% FCS, and 1 mM DTT) and was incubated for 45 min on a rotor at
37C. The rest of the intestine was removed, and the epithelial clumps were
collected by centrifugation at 800 rpm for 5 min and washed in PBS.
B Cell Isolation
For B cell isolation, spleen was cut into small fragments and digested with col-
lagenase and DNase, followed by the addition of EDTA. Subsequently, cells
were incubated with anti-CD45R, anti-CD3, and anti-CD49b (BD PharMingen).
B cells were selected as cells that stained positive for CD45R (B220) (Coffman,
1982) and negative for both anti-CD3 and anti-CD49b and were then sorted by
using a FACS Aria system (Becton Dickinson).
Mass Spectrometry
For protein separation, samples were loaded on a NuPAGE 4%–12% Bis-Tris
gel (Invitrogen). After staining of the gel with the Colloidal Blue Staining Kit
(Invitrogen), evenly sized gel pieces were excised from the gel and processed
for enhanced liquid chromatography-mass spectrometry (GeLC-MS).
For blood analysis, Coomassie-stained gel lanes were cut into eight pieces.
To determine incorporation ratios, we analyzed three gel pieces per lane from
heart, gut epithelia, liver, red blood cell, and platelet samples.
The gel pieces were subjected to in-gel reduction and alkylation, followed by
LysC digestion as previously described (Andersen et al., 2005; Shevchenko
et al., 1996). Finally, peptides were extracted twice by adding an equal volume
of 30% acetonitrile/0.3% trifluoraceticacid (TFA) in water to digest the mixture,
followed by a final extraction with 100% acetonitrile. Extracts were evaporated
in a speedvac to remove acetonitrile and were subsequently acidified with
0.5% TFA. Samples were desalted and concentrated with StageTips and
were resuspended in 5 ml of 0.5% acetic acid/1% TFA (Rappsilber et al.,
2003). In-solution digestion of proteins was performed as described by Ong
and Mann (2006).
Reverse-phase nano-LC-MS/MS was performed by using an Agilent 1100/
1200 nanoflow LC system (Agilent Technologies) with a cooled, thermostated
96-well autosampler. The LC system was coupled to a 7-Tesla LTQ-FT or LTQ
Orbitrap instrument (Thermo Fisher Scientific) equipped with a nanoeletros-
pray source (Proxeon). Chromatographic separation of peptides was per-
formed in a 10 cm long 8 mm tip opening/75 mm inner diameter capillary needle
(Proxeon). The column was custom made with methanol slurry of reverse-
phase ReproSil-Pur C18-AQ 3 mm resin (Dr. Maisch, GmbH). The LysC-di-
gested peptide mixtures were autosampled at a flow rate of 0.5 ml/min and
then eluted with a linear gradient at a flow rate of 0.25 ml/min. The mass spec-
trometers were operated in the data-dependent mode to automatically mea-
sure MS and MS/MS. LTQ-FT full scan MS spectra (from m/z 300 to m/z
1600) were acquired with a resolution of R = 100,000 at m/z 400 (after accumu-
lation to a target value of 3,000,000 in the linear ion trap). The five most intense
ions were sequentially isolated and fragmented in the linear ion trap by using
collisionally induced dissociation at a target value of 10,000 (Olsen et al., 2004).
Raw data files were converted to Mascot generic format files with in-
house software (Raw2MSM), and Mascot (version 2.0) was used for a
database search and protein identification. The following search
parameters were used in all MASCOT searches: LysC digest; no missed
cleavage; carbamidomethylation of cysteine set as a fixed modification; and
oxidation of methionines and L-lysine-6 allowed as variable modifications.
The maximum allowed mass deviation for MS and MS/MS scans was 10
ppm and 0.5 Da, respectively. Only proteins that had at least two peptides
with ion scores >20 were considered for identification and quantitation.
MSQuant (Schulze andMann, 2004) was used to verify and quantify the result-
ing SILAC-peptide pairs. All proteomic results were deposited in the publicly
accessible MAPU database (Zhang et al., 2007). A target decoy database ap-
proachwas used to identify false-positive peptides and to set threshold criteria
such that <1% false positives were included in the peptide list (Tables S1 and
S2, statistics sheet). After mass recalibration withMSQuant, the average abso-
lute mass error of all peptides was better than 3 ppm.
Samples from all mouse mutants were analyzed by the in-house-developed
software MaxQuant (Cox and Mann, 2007; Graumann et al., 2008). Briefly,
MaxQuant performs a peak list, SILAC- and XIC-based quantitation, false-
positive rates (Gingras et al., 2007), and peptide identification based on Mas-
cot search results.
All data were searched against the International Protein Index sequence da-
tabase (mouse IPI, version 3.24) (Kersey et al., 2004). Fold-change for ghost
proteins was determined from the gel slice corresponding to the expected
migration of the full-length protein.
Blood Cell Analyses
Hematocrit was measured from peripheral blood with a hematology analyzer
(Nihon Kohden).
For ‘‘ghost’’ preparation,erythrocyteswerewashed twice in0.9%NaCl, 10mM
sodium phosphate buffer (pH 7.0) before hypotonic lysis were performed in
0.25% NaCl, 10 mM sodium phosphate buffer (pH 7.0). Lysis was performed
in several rounds in hypotonic buffer until the pellet became white.
Flow Cytometry
Flow cytometric lacZ staining of hematopoietic cells was performed on
Ter119-positive bone marrow cells that have been incubated with the fluores-
cent b-galactosidase substrate FDG (fluorescein di-b-D-galactopyranoside)
(Sigma) as described (Montanez et al., 2007). Flow cytometry was carried
out on a Becton Dickinson FACSCalibur.
SUPPLEMENTAL DATA
Supplemental Data include seven figures and eight tables for protein identifi-
cation and quantification and are available with this article online at http://
www.cell.com/cgi/content/full/134/2/353/DC1/.
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